Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 1
2001 3
2002 1
2003 3
2004 1
2005 3
2006 5
2007 9
2008 2
2009 4
2010 4
2011 5
2012 7
2013 5
2014 2
2015 1
2016 2
2017 4
2018 7
2019 11
2020 11
2021 19
2022 13
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.
Gill H, Leung GMK, Ooi MGM, Teo WZY, Wong CL, Choi CW, Wong GC, Lao Z, Rojnuckarin P, Castillo MRID, Xiao Z, Hou HA, Kuo MC, Shih LY, Gan GG, Lin CC, Chng WJ, Kwong YL. Gill H, et al. Among authors: rojnuckarin p. Clin Exp Med. 2023 Dec;23(8):4199-4217. doi: 10.1007/s10238-023-01189-9. Epub 2023 Sep 25. Clin Exp Med. 2023. PMID: 37747591 Review.
RNA-Sequencing of Snake Venom Glands.
Yee KT, Vasieva O, Rojnuckarin P. Yee KT, et al. Among authors: rojnuckarin p. Methods Mol Biol. 2020;2068:87-96. doi: 10.1007/978-1-4939-9845-6_5. Methods Mol Biol. 2020. PMID: 31576524
National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries.
Chuansumrit A, Ruchutrakul T, Sirachainan N, Kitpoka P, Panuwannakorn M, Panburana P, Suwannuraks M, Sri-Udomporn N, Kijkunasathian C, Jaovisidha S, Utamakul C, Natesirinilkul R, Pongtanakul B, Traivaree C, Komvilaisak P, Suwantaroj E, Sosothikul D, Angchaisuksiri P, Rojnuckarin P. Chuansumrit A, et al. Among authors: rojnuckarin p. Expert Rev Hematol. 2023 Jul-Dec;16(12):1063-1076. doi: 10.1080/17474086.2023.2293092. Epub 2023 Dec 18. Expert Rev Hematol. 2023. PMID: 38100503 Review.
Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.
Moonla C, Polprasert C, Komvilaisak P, Rattanathammethee T, Kongkiatkamon S, Wudhikarn K, Kobbuaklee S, Boonyabaramee P, Tangcheewinsirikul N, Pakakasama S, Rujkijyanont P, Choed-Amphai C, Phuakpet K, Pongudom S, Bunworasate U, Sukswai N, Sosothikul D, Rojnuckarin P. Moonla C, et al. Among authors: rojnuckarin p. Haematologica. 2023 Oct 1;108(10):2743-2752. doi: 10.3324/haematol.2022.282419. Haematologica. 2023. PMID: 37051767 Free PMC article.
Genetic mutations associated with blood count abnormalities in myeloid neoplasms.
Polprasert C, Kongkiatkamon S, Niparuck P, Rattanathammethee T, Wudhikarn K, Chuncharunee S, Kobbuaklee S, Suksusut A, Lanamtieng T, Lawasut P, Asawapanumas T, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: rojnuckarin p. Hematology. 2022 Dec;27(1):765-771. doi: 10.1080/16078454.2022.2094134. Hematology. 2022. PMID: 35766510
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Röth A, He G, Tong H, Lin Z, Wang X, Chai-Adisaksopha C, Lee JH, Brodsky A, Hantaweepant C, Dumagay TE, Demichelis-Gómez R, Rojnuckarin P, Sun J, Höglund M, Jang JH, Gaya A, Silva F, Obara N, Kelly RJ, Beveridge L, Buatois S, Chebon S, Gentile B, Lundberg P, Sreckovic S, Nishimura JI, Risitano A, Han B. Röth A, et al. Among authors: rojnuckarin p. Am J Hematol. 2024 Sep;99(9):1768-1777. doi: 10.1002/ajh.27412. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884175 Clinical Trial.
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C, Niparuck P, Rattanathammethee T, Chuncharunee S, Kobbuaklee S, Songserm K, Suksusut A, Trithiphen S, Lanamtieng T, Kongkiatkamon S, Chanswangphuwana C, Lawasut P, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: rojnuckarin p. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e293-e299. doi: 10.1016/j.clml.2021.10.015. Epub 2021 Nov 2. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34840089
122 results